LYZER DIAGNOSTICS

About:

It is developing two proprietary testing platforms that will enable healthcare providers and life science researchers to better manage

Website: http://eveiamedical.com

Description:

It is developing two proprietary testing platforms that will enable healthcare providers and life science researchers to better manage patients, diagnose disease and develop targeted therapeutics and diagnostics. The Rapid Testing (Point-of-Care) technology enables cost-effective management of many of the most common disease states, and completely eliminates the need for any instrumentation and reagents. Single use devices in development include tests for anemia (Hb), coagulation (Coumadin therapy), c-Reactive Protein (CRP), HbA1c and numerous other applications in clinical medicine.

Total Funding Amount:

$1.34M

Headquarters Location:

Boulder, Colorado, United States

Founded Date:

2007-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2008-01-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai